In a report released today, Matt Miksic from Barclays maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of ...

At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...

New report from Sperling's BestPlaces and Medtronic highlights the cities they may call home NORTHAMPTON, MA / ACCESS ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

How mission plus performance can lead to sustainable success.

Transforming the way we power our community, one turbine at a time NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its ...

Medtronic (NYSE: MDT) + announced study findings highlighting significant disparities in cardiac care following stroke. The ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Hold rating on Medtronic (MDT – Research Report), with a price ...